ERBB2 and breast cancer: Peng et al. [77] constructed Herceptin-conjugated PCL-PEG worm-like nanocrystal micelles for HER2+ breast cancer using paclitaxel (PTX) and Herceptin and found them stable in blood circulation and TME with specific HER2+ tumor cells targeting.